Nucala 100 MG/ML auto-injectorml
Ended Awarded
- Contract number
- SPE2DB25FTKRL
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,679
Award facts
- Contract value 100% obligated
- $5,678.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $5,678.70 by the Defense Logistics Agency (DLA) on September 26, 2025. The delivery order, which has an ultimate completion date of September 29, 2025, covers the supply of Nucala 100 mg/ml auto-injector units to support federal healthcare operations. This award was issued without a set-aside designation, allowing the company to compete on an open basis despite its small business status. The contract represents a continuation of DMS Pharmaceutical Group's substantial involvement in the federal pharmaceutical supply chain.
This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, which is valued at $499,999,999 and extends through November 2026. The underlying IDC enables the DLA to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to support Department of Defense healthcare facilities worldwide. Through this vehicle, DMS Pharmaceutical Group has established itself as a critical supplier for specialty pharmaceutical products, including various auto-injectors, oncology treatments, and injectable medications essential to military medical operations.
Quick answers
Who was awarded contract SPE2DB25FTKRL?
SPE2DB25FTKRL was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FTKRL worth?
The government has obligated $5,679 on SPE2DB25FTKRL.
Is contract SPE2DB25FTKRL an order under another contract?
Yes. SPE2DB25FTKRL is a delivery order under SPE2DB22D9112, an indefinite delivery contract.
Was contract SPE2DB25FTKRL competed?
The extent of competition for SPE2DB25FTKRL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award